VOQUEZNA met its primary endpoint in its Phase 3 pivotal trial by demonstrating a significant and rapid reduction of heartburn with daily treatment VOQUEZNA represents the first major innovation in ...

One of the largest pharmacy benefit management (PBM) companies in the United States has added VOQUEZNA (vonoprazan) tablets to its national formularies for commercial plans, effective immediately ...

June 6 (Reuters) - Generic drugmaker Perrigo Co. said a federal court ruled in its favor in patent litigation involving its over-the-counter Famotidine tablets used for treatment of heartburn due to ...

Omeprazole ranks amongst the most frequently prescribed medications in the UK. The latest figures reveal that 73 million NHS prescriptions for proton pump inhibitors (PPIs), such as Omeprazole, were ...